
NMPA approves novel globally trialled therapy before US, Japan, Europe
What China’s first approval ahead of major regulators means for biopharma strategy, timelines, and competitive pressure.

Curating from trusted global sources…
121 briefings · “tor”

What China’s first approval ahead of major regulators means for biopharma strategy, timelines, and competitive pressure.

A possible lease and operator shift could bring the Hollywood landmark back, but only after expensive code-heavy upgrades.

Secondary-market bidders are paying premium prices for access to Elon Musk's AI and robotics bets, even as valuations stay murky.

Foreign Policy argues the rhetoric on China meddling doesn’t align with the president’s actual China approach.

The James Webb Space Telescope peels back how early galaxies seeded stars with metals, using a nearby dwarf as a stand-in.
New Florida International University simulations suggest mergers are not the universal kill switch for star formation.
A potential Middle East escalator could dominate US politics, markets, and alliance management for years, not months.

In The Stunt Driver trailer, the Canadian daredevil rivalry turns into a biopic comedy, launching Sept. 25.

A White House report called the museum insufficiently patriotic. Now lawmakers are putting the museum director on the hot seat.

A sudden leadership shake-up follows street protests, with Zelensky replacing a Soviet-trained top commander.

The job cuts are unspecified, but the timing matters: investors are rewarding a turnaround while Intel retools AI and Xeon.

Disney's Marvel put tickets on sale with the first trailer launch, and the early take signals box-office momentum.